Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML
Nyquist, Emil, Dalgaard, Jakob, Spetalen, Signe, Torkildsen, Synne, Frøen, Hege, Galteland, Eivind, Klungsøyr, Ole, Bergrem, Astrid, Vo, Camilla Dao, Sørbø, Hjalmar, Eiken, Birgitte, Lerdal, Hedda, Solvang, Ann-Karin, Jensvoll, Hilde, Pandzic, Tatjana, Baliakas, Panagiotis, Dybedal, Ingunn
Published in British journal of haematology (2023)
Get full text
Published in British journal of haematology (2023)
Journal Article
Pathogenic DDX41 variants, possible response predictors to low‐dose melphalan in hypo‐ and normocellular MDS and AML
Nyquist, Otto Emil, Dalgaard, Jakob, Spetalen, Signe, Torkildsen, Synne, Frøen, Hege, Galteland, Eivind, Klungsøyr, Ole, Bergrem, Astrid, Vo, Camilla, Sørbø, Hjalmar, Eiken, Birgitte, Lerdal, Hedda, Solvang, Ann‐Karin, Jensvoll, Hilde, Pandzic, Tatjana, Baliakas, Panagiotis, Dybedal, Ingunn
Published in British journal of haematology (01.02.2024)
Published in British journal of haematology (01.02.2024)
Get full text
Journal Article
Will Survival Improve By Treating Multiple Myeloma Patients at MRD Relapse? the Remnant Study
Askeland, Frida Bugge, Rasmussen, Anne-Marie, Lysen, Anna, Haukås, Einar, Eilertsen, Anette Løken, Moksnes, Magnus, Tsykunova, Galina, Vik, Anders, Eiken, Birgitte Dahl, Stavseth, Vidar, Rolke, Jürgen, Samstad, Eivind Ottersen, Peceliunas, Valdas, Hallstensen, Randi Fykse, Hansen, Ariane Aasbø, Nilsen, Anita Smith, Slørdahl, Tobias S., Schjesvold, Fredrik
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
P-082 Will survival improve by treating multiple myeloma patients at MRD relapse? The REMNANT study
Rasmussen, Anne-Marie, Askeland, Frida, Lysen, Anna, Haukås, Einar, Eilertsen, Anette, Tsykunova, Galina, Vik, Anders, Eiken, Birgitte, Stavseth, Vidar, Rolke, Jürgen, Samstad, Eivind, Peceliunas, Valdas, Hallstensen, Randi Fykse, Hansen, Ariane Aasbø, Nilsen, Anita Smith, Slørdahl, Tobias, Schjesvold, Fredrik
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article